Patent Assignment
Reel/Frame 061092/0709
Assignment of Assignor's Interest
Recorded: 2022-09-14
Pages: 3
Assignee
CELLULAR BIOMEDICINE GROUP HK LIMITED
ROOM 417, 4TH FLOOR, LIPPO CENTRE, TOWER TWO, NO.89 QUEENSWAY, ADMIRALTY, HONG KONG, CHINA
Covered Property
(1)
Combined Chimeric Antigen Receptor Targeting CD19 and CD20 and Applications Thereof
Application:
17/911,524 →
Publication:
US 2023/0212255
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 14, 2022
From: YAO, YIHONG; HUANG, JIAQI; YAO, XIN; ZHU, SHIGUI
To: CELLULAR BIOPHARMACEUTICAL GROUP HK LTD.; SHANGHAI CELLULAR BIOPHARMACEUTICAL GROUP LTD.; WUXI CELLULAR BIOPHARMACEUTICAL GROUP LTD.; CELLULAR BIOMEDICINE GROUP INC.
Reel/Frame 061092/0404 →
Assignment of Assignor's Interest
Sep 14, 2022
From: SHANGHAI CELLULAR BIOPHARMACEUTICAL GROUP LTD.
To: CELLULAR BIOMEDICINE GROUP HK LIMITED
Reel/Frame 061092/0494 →
Assignment of Assignor's Interest
Sep 14, 2022
From: WUXI CELLULAR BIOPHARMACEUTICAL GROUP LTD.
To: CELLULAR BIOMEDICINE GROUP HK LIMITED
Reel/Frame 061092/0545 →
Assignment of Assignor's Interest
Sep 14, 2022
From: CELLULAR BIOMEDICINE GROUP INC.
To: CELLULAR BIOMEDICINE GROUP HK LIMITED
Reel/Frame 061092/0613 →
Assignment of Assignor's Interest
Dec 15, 2022
From: CELLULAR BIOMEDICINE GROUP HK LTD.
To: CELLULAR BIOMEDICINE GROUP INC.
Reel/Frame 062100/0469 →
Change of Name
Jan 19, 2024
From: CELLULAR BIOMEDICINE GROUP, INC.
To: ABELZETA INC.
Reel/Frame 066356/0108 →